Idorsia Ltd reports positive top-line results of the first pivotal Phase 3 study investigating 25 and 50 mg doses of its dual orexin receptor antagonist, daridorexant, in 930 adult and elderly patients with insomnia.
Read MoreCleveland Clinic’s Nancy Foldvary-Schaefer, DO, MS. shares advice on insomnia treatments.
Read MoreHarmony Biosciences LLC will expand narcolepsy community support efforts and reinforce its commitment to provide affordable access to treatment for people who have experienced a change in insurance or financial instability during the ongoing COVID-19 pandemic.
Read MoreThe American Academy of Sleep Medicine congratulates the three students selected as the winners of the 2020 AASM High School Video Contest, which focused on educating teens about the importance of healthy sleep.
Read MoreOlder adults with depression may be at much higher risk of remaining depressed if they are experiencing persistent or worsening sleep problems.
Read More